Lidocaine Infusion in Hystroscopy | Clinical Trial

Key information

Conditions

Pain Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Ain Shams University Maternity Hospital

Cairo, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18-35 years
BMI 18.5-30 kg/m2
Diagnostic hystroscope

Exclusion criteria

Previous cervical surgery
Cervical stenosis
PID
allergy to NSAID
Gastritis or peptic ulcer

Treatment and study plan

Lidocaine Hydrochloride

Drug

Lidocaine infusion on hystroscopic media during office hystroscopy

Diclofenac Sodium

Drug

Oral Diclofenac Sodium

Primary outcomes

Degree of pain "measured by visual analogue scale"

Time frame: 1 hour

measured by visual analogue scale

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Lidocaine Infusion Versus Oral Diclofenac During Outpatient Hystroscopy: A Randomized Clinical Trial

Important dates

Study start: 2017
Primary completion: 2020
Study completion: 2020
First posted: Jan 31, 2019
Registry last updated: Jan 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed